Synartro

Synartro Overview

Status Acquired/​Merged
Latest Deal Type M&A
Financing Rounds 1

Synartro General Information

Description

Developer of anti-inflammatory drug using the drug delivery technology. The company is involved in developing a pipeline of repositioned drug candidates for important medical needs.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • Uppsala
  • Sweden
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synartro Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Synartro‘s full profile, request access.

Request a free trial

Synartro Executive Team (1)

Name Title Board Seat Contact Info
Rune Ringom Chief Executive Officer